Rosseto et al. 2015 1717. Bural C, Aktaş E, Deniz G, Ünlüçerçi Y, Bayraktar G. Effect of leaching residual methyl methacrylate concentrations on in vitro cytotoxicity of heat polymerized denture base acrylic resin processed with different polymerization cycles. J Appl Oral Sci. 2011 Aug;19(4):306-12. https://doi.org/10.1590/S1678-77572011005000002
https://doi.org/10.1590/S1678-7757201100...
|
R |
45 |
45 |
31.9 |
37 |
8 |
Skull |
PMMA: 29 (64%) AB: 16 (36%) |
1 |
NR |
PMMA: 9 (31%) AB: 2 (12.5%) |
63–797 |
Bobinski et al. 2013 1212. Akan M, Karaca M, Eker G, Karanfil H, Aköz T. Is polymethylmethacrylate reliable and practical in full-thickness cranial defect reconstructions? J Craniofac Surg. 2011 Jul;22(4):1236-9. https://doi.org/10.1097/SCS.0b013e31821c0f34
https://doi.org/10.1097/SCS.0b013e31821c...
|
R |
49 |
49 |
43.2 |
38 |
11 |
Skull |
PMMA: 19 (38.8%) AB: 30 (61.2%) |
1 |
T: 49 (100%) |
PMMA: 4 (21.1%) AB: 16 (53.3%) |
1629 |
Klinger et al. 20131515. Ata SO, Yavuzyilmaz H. In vitro comparison of the cytotoxicity of acetal resin, heat-polymerized resin, and auto-polymerized resin as denture base materials. J Biomed Mater Res B Appl Biomater. 2009 Nov;91(2):905-9. https://doi.org/10.1002/jbm.b.31473
https://doi.org/10.1002/jbm.b.31473...
|
R |
249 |
258 |
44 |
157 |
92 |
Skull |
PMMA: 120 (47%) AB: 138 (53%) |
1 and 2 |
T: 118 (47%) NT: 140 (53%) |
PMMA: 7 (5.8%) AB: 14 (8.6%) Without information: 9 (3.5%)* |
NR |
Al- Tamimi et al. 201255. Shah AM, Jung H, Skirboll S. Materials used in cranioplasty: a history and analysis. Neurosurg Focus. 2014 Apr;36(4):E19. https://doi.org/10.3171/2014.2.FOCUS13561
https://doi.org/10.3171/2014.2.FOCUS1356...
|
P |
126 |
126 |
42 |
NR |
NR |
Skull |
PMMA: 61 (48.4%) Ti : 65 (51.6%) |
1 |
T: 55 (43.65%) NT: 71 (56.35%) |
PMMA: 5 (8.2%) Ti Mesh: 8 (12.3%) |
PMMA: 2916 Ti: 1020 |
Sahoo et al. 201011. Zanotti B, Zingaretti N, Verlicchi A, Robiony M, Alfieri A, Parodi PC. Cranioplasty: review of materials. J Craniofac Surg. 2016 Nov;27(8):2061-72. https://doi.org/10.1097/SCS.0000000000003025
https://doi.org/10.1097/SCS.000000000000...
|
R |
22 |
22 |
27 |
27 |
0 |
Occipital (4) Parietal (8) Frontoparietal (5) Occipto-parietal (3) Frontal (2) |
PMMA: 5 (22.7%) AB: 11 (50%) Ti Mesh: 6 (27.3%) |
1 |
T: 20 (91%) NT: 2 (9%) |
PMMA: 4 (80%) AB: 0 (0%) Ti Mesh: 3 (50%) |
540–720 |
Cheng et al. 20081616. Barron DJ, Schuster GS, Caughman GB, Lefebvre CA. Biocompatibility of visible light-polymerized denture base resins. Int J Prosthodont. 1993 Sep-Oct;6(5):495-501.
|
P |
75 |
84 |
44.3 |
62 |
22 |
Skull |
PMMA: 32 (38%) AB: 52 (62%) |
1 and 2 |
T: 60 (71.4%) NT: 24 (28.6%) |
PMMA: 2 (6.25%) AB: 7 (13.5%) |
1440 |
Matsuno et al. 20061414. Jaberi J, Gambrell K, Tiwana P, Madden C, Finn R. Long-term clinical outcome analysis of poly-methyl-methacrylate cranioplasty for large skull defects. J Oral Maxillofac Surg. 2013 Feb;71(2):e81-8. https://doi.org/10.1016/j.joms.2012.09.023
https://doi.org/10.1016/j.joms.2012.09.0...
|
R |
206 |
206 |
39.2 |
124 |
82 |
Skull |
PMMA: 58 (28.2%) AB: 54 (26.2%) Ti Mesh: 77 (37.4%) Ceramic: 17(8.2%) |
1 |
T: 64 (31%) NT: 142 (69%) |
PMMA: 8 (13.8%) AB: 14 (25.9%) Ti Mesh: 2 (2.6%) Ceramic: 1 (5.9%) |
1834 |
Josan et al. 20051919. Khader BA, Towler MR. Materials and techniques used in cranioplasty fixation: A review. Mater Sci Eng C. 2016 Sep;66:315-22. https://doi.org/10.1016/j.msec.2016.04.101
https://doi.org/10.1016/j.msec.2016.04.1...
|
R |
24 |
28 |
8.1 |
13 |
11 |
Skull |
PMMA: 3 (10.7%) AB: 16 (57.1%) Ti : 1 (3.6) Split calvarium graft: 8 (28.6%) |
1 and 2 |
T: 11 (39.3%) NT: 17 (60.7%) |
PMMA: 0 (0%) AB: 5 (18%) Ti : 0 (0%) |
540 |
Bandyopadhyay et al 20051818. Goiato MC, Anchieta RB, Pita MS, dos Santos DM. Reconstruction of skull defects: currently available materials. J Craniofac Surg. 2009 Sep;20(5):1512-8. https://doi.org/10.1097/SCS.0b013e3181b09b9a
https://doi.org/10.1097/SCS.0b013e3181b0...
|
R |
17 |
17 |
26.5 |
NR |
NR |
Frontal (6) Parietal (3) Frontoparietal (2) Frontoparietal + supra orbital (1) Temporal (1) Temporo-parietal (1) parietum-occipital (1) |
PMMA: 12 (70.6%) Ti : 2 (11.8%) PMMA and Ti : 3 (17.6%) |
1 |
T: 15 (88.2%) NT 2 (11.96%) |
PMMA: 0 (0%) Ti : 0 (0%) Ti and PMMA: 0 (0%) |
NR |
Lee et al. 200422. Andrabi SM, Sarmast AH, Kirmani AR, Bhat AR. Cranioplasty: Indications, procedures, and outcome: an institutional experience. Surg Neurol Int. 2017 May;8(1):91. https://doi.org/10.4103/sni.sni_45_17
https://doi.org/10.4103/sni.sni_45_17...
|
R |
131 |
131 |
37.5 |
88 |
43 |
NR |
PMMA: 40 (30.5%) AB: 91 (69.5%) |
1 |
T: 101 (77%) NT: 30 (23%) |
PMMA: 6 (15%) AB: 5 (5.5%) |
180 |
Gonzalez et al. 200344. Aydin S, Kucukyuruk B, Abuzayed B, Aydin S, Sanus GZ. Cranioplasty: review of materials and techniques. J Neurosci Rural Pract. 2011 Jul;2(2):162-7. https://doi.org/10.4103/0976-3147.83584
https://doi.org/10.4103/0976-3147.83584...
|
R |
312 |
312 |
31.9 |
175 |
146 |
Frontal (53,2%) Temporal (23,4%) parietum-mastoid (23,4%) |
PMMA: 52 (16.7%) AB: 217(69.5%) Hydroxyapatite: 40 (12.9%) |
1 and 2 |
T: 99 (31.8%) NT: 213 (68.2%) |
PMMA: 16 (29.3%) AB: 45 (20.5%) Hydroxyapatite: 13 (32.8%) |
1188 |